Welcome to our dedicated page for Kisses From Italy news (Ticker: KITL), a resource for investors and traders seeking the latest updates and insights on Kisses From Italy stock.
Kisses From Italy Inc. reports news about its transition from an Italian food franchising and product-distribution business toward a healthcare-oriented platform following its Regen Health Physicians combination. Recent company updates describe biologics, regenerative medicine, aesthetic wellness, longevity services, clinic expansion, acquisition-oriented growth, and leadership changes.
Earlier KITL news centered on restaurant franchising, branded Italian food products, The Ponte San'gwich Shoppe & Italian Deli, retail distribution, online sales, logistics relationships, and North American product fulfillment. Recurring announcements also covered board appointments, franchise-development relationships, retail product launches, and distribution opportunities in the United States, Canada, and Europe.
Kisses From Italy (OTC Pink: KITL) announced a business combination with Regen Health Physicians, named Dr. Ajit Dhaliwal as CEO, and unveiled an aggressive 2026 expansion plan into biologics, peptide therapy, and longevity care. The company says it is operational in New York City and Salt Lake City with planned rollouts to Miami and San Francisco.
The release highlights a franchise and licensing model, a subsidiary focused on men's health, and market context citing a $21.47B medspa market (2025) and a $117B peptide therapeutics market (2024) as growth drivers. KITL is completing its year-end disclosure filing.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.